Issued Patents 2019
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10479795 | Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors | Andrew W. Buesking, Andrew P. Combs, Brent Douty, Nikoo Falahatpisheh, Lixin Shao +5 more | 2019-11-19 |
| 10472368 | Heterocyclic compounds as PI3K-γ inhibitors | Artem Shvartsbart, Stacey Shepard, Andrew P. Combs, Lixin Shao, Nikoo Falahatpisheh +4 more | 2019-11-12 |
| 10464947 | Tricyclic heterocycles as BET protein inhibitors | Andrew P. Combs, Thomas P. Maduskuie, Jr., James D. Rodgers | 2019-11-05 |
| 10376513 | Heterocyclylamines as PI3K inhibitors | Andrew P. Combs, Brent Douty, Yun-Long Li, Song Mei, Eddy W. Yue | 2019-08-13 |
| 10369137 | 1,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | Andrew P. Combs, Eddy W. Yue, Wenyu Zhu | 2019-08-06 |
| 10259818 | Bicyclic azaheterocyclobenzylamines as PI3K inhibitors | Andrew P. Combs, Thomas P. Maduskuie, Jr. | 2019-04-16 |
| 10227359 | Tricyclic heterocycles as bet protein inhibitors | Andrew P. Combs | 2019-03-12 |